Feature | November 05, 2014

CMS Issues Ruling on 2015 Mammography Screening Reimbursement Rates

Separate codes created for screening mammography versus diagnostic mammography

November 5, 2014 — Hologic, Inc. announced that the Centers for Medicare and Medicaid Services (CMS) has released reimbursement rates for screening and diagnostic 3-D mammography. The action establishes national average payment rates for the Category I Current Procedural Terminology (CPT) code for 3-D screening mammography and creates a new add-on Healthcare Common Procedure Coding System (HCPCS) code for 3-D diagnostic mammography.

The Medicare payment rates will go into effect Jan. 1, 2015, and will allow providers in the United States to file reimbursement claims specific to screening and diagnostic 3-D mammography. The CMS Medicare Physician Fee Schedule Final Rule not only sets reimbursement rates for 3-D mammography, but also creates a pathway for private insurers to explore broader coverage and payment options. The rates are as follows:

  • 3-D screening mammography CPT code, 77063, assigned a payment rate of approximately $57. This is an add-on to the existing 2-D mammography screening code, G0202, with an assigned payment rate of approximately $135.
  • 3-D diagnostic mammography HCPCS code, G0279, assigned a payment rate of approximately $57 for either unilateral or bilateral images.  
    • This is an add-on to the existing 2-D mammography unilateral diagnostic code, G0206, with an assigned payment rate of approximately $130. 
    • This is an add-on to the existing 2-D mammography bilateral diagnostic code, G0204, with an assigned payment rate of approximately $165.

For more information www.hologic.com

Related Content

Christopher Comstock, M.D., ECOG-ACRIN Cancer Research Group study published in JAMA builds evidence for use of abbreviated MRI in women with dense breasts

Christopher Comstock, M.D., (Memorial Sloan Kettering Cancer Center) is the lead author of a paper in JAMA that reports that abbreviated breast MRI detected significantly more (almost 2 and a half times as many) breast cancers than digital breast tomosynthesis (3-D mammography) in average-risk women with dense breasts. Photo courtesy of Memorial Sloan Kettering Cancer Center

News | Breast Imaging | February 26, 2020
February 26, 2020 — According to a study
Women 75-plus May Not Benefit from Breast Cancer Screening
News | Mammography | February 25, 2020
February 25, 2020 — According to newly published research in an article titled...
Images in a 41-year-old woman who presented with fever and positive polymerase chain reaction assay for the 2019 novel coronavirus (2019-nCoV) #coronavirus #nCoV2019 #2019nCoV #COVID19

Images in a 41-year-old woman who presented with fever and positive polymerase chain reaction assay for the 2019 novel coronavirus (2019-nCoV). Three representative axial thin-section chest CT images show multifocal ground glass opacities without consolidation. Three-dimensional volume-rendered reconstruction shows the distribution of the ground-glass opacities (arrows). Image courtesy of the Radiological Society of North America (RSNA)

News | Radiology Imaging | February 25, 2020
February 24, 2020 — The U.S.
Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Radiology Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
Esaote, an Italian company among the world leaders in the field of medical diagnostic imaging systems, is the Ducati Team's official partner for the 2020 season
News | Radiology Business | February 14, 2020
February 14, 2020 — Esaote, an Italian company among the world le
Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.